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Abstract
Injury and violence prevention strategies have greater potential for impact when they are based on 
scientific evidence. Systematic reviews of the scientific evidence can contribute key information 
about which policies and programs might have the greatest impact when implemented. However, 
systematic reviews have limitations, such as lack of implementation guidance and contextual 
information, that can limit the application of knowledge. “Technical packages,” developed by 
knowledge brokers such as the federal government, nonprofit agencies, and academic institutions, 
have the potential to be an efficient mechanism for making information from systematic reviews 
actionable. Technical packages provide information about specific evidence-based prevention 
strategies, along with the estimated costs and impacts, and include accompanying implementation 
and evaluation guidance to facilitate adoption, implementation, and performance measurement. 
We describe how systematic reviews can inform the development of technical packages for 
practitioners, provide examples of technical packages in injury and violence prevention, and 
explain how enhancing review methods and reporting could facilitate the use and applicability of 
scientific evidence.
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Over the past thirty years, the nature of public health practice has evolved such that state, 
tribal, local, and territorial (STLT) health agency practitioners are expected to use the best 
available evidence when selecting policy and program strategies. Such expectations are 
demonstrated within major federal funding initiatives across areas of health and social policy 
that grow the number of strategies supported by rigorous effectiveness research and 
prioritize funds for “top tier” evidence strategies (Haegerich, Gorman-Smith, Wiebe, & 
Yonas, 2010). Broadly, evidence encompasses information gathered from research (e.g., 
public health surveillance and program evaluations in the scientific literature); about 
population characteristics, needs, values, and preferences; and about resources available, 
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including practitioner expertise, all within a given environment and organizational context 
(Brownson, Fielding, & Maylahn, 2009).
Evidence supporting injury and violence prevention is strong, and reflects a broad spectrum 
of education, behavior change, policy, engineering, and environmental strategies (Haegerich, 
Dahlberg, Simon, Baldwin, Sleet, Greenspan, & Degutis, 2014). The need for prevention 
strategies is critical, as injuries and violence are leading causes of death across the lifespan 
and pose a significant public health burden. For example, unintentional injury and homicide 
are among the top 5 leading causes of death for individuals aged 1–44 years. Drug overdose 
is the leading cause of injury death for all ages, followed by motor vehicle injury. The 
burden of homicide is felt particularly among young people ages 15 to 24 years (CDC, 
2014). Given the health burden and strong research foundation for prevention, injury and 
violence prevention is an area of public health and social policy that needs greater 
application of evidence to practice (Haegerich et al., 2010; Sogolow, Sleet, & Saul, 2007). 
As conveners across multiple disciplines with a focus on improving community wellness, 
STLT health agencies are uniquely positioned to build collaboration and capacity across 
sectors that are invested in injury and violence prevention (e.g., transportation, justice, 
mental health, and substance abuse services), and promote increased use of evidence-based 
strategies.
Leaders of the movement toward evidence-based public health have identified three clear 
needs: (1) identify the evidence of effectiveness for different strategies; (2) translate that 
evidence into recommendations; and (3) increase the extent to which that evidence is used in 
public health practice (Brownson, Baker, Leet, & Gillespie, 2003).
Systematic reviews are a fundamental tool for meeting the first need (Brownson et al. 2009), 
as they efficiently summarize the findings of multiple studies. Systematic reviews, although 
useful, can be challenging for STLT agency practitioners to use easily. Common barriers to 
use include lack of access, awareness, familiarity, usefulness, and training; for example, 
practitioners are not always familiar with or have access to electronic tools that assist them 
in identifying evidence, such as PubMed (Wallace, Nwosu, & Clarke, 2012). The Institute of 
Medicine (2001) delivered a sentinel call to action to close the gap between research and 
practice, citing a 17 year delay between the discovery of evidence using rigorous methods 
and the use of such evidence in practice settings (Balas & Boren, 2000). Federal agencies, 
nonprofit foundations, and academic institutions can serve as knowledge brokers to help to 
close this gap by translating systematic review findings into practice guidance. Such 
translation activities can be bolstered by developing relationships, providing support, and 
building capacity of STLT agency practitioners (Dobbins et al., 2009); for example, through 
training and technical assistance to enhance implementation of evidence-based strategies, 
and evaluation guidance to allow for monitoring and improvement.
Organizational groups are facilitating access to scientific findings to improve public health 
and social policy. These include the Cochrane and Campbell collaborations that prepare, 
maintain, and promote the accessibility of systematic reviews, and efforts of the Community 
Preventive Services Task Force and the US Preventive Services Task Force that develop 
public health and clinical practice recommendations based on systematic reviews (Davies & 
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Boruch, 2001; Grimshaw, Santesso, Cumpston, Mayhew, & McGowan, 2006; Harris et al., 
2001; Briss et al., 2000).
One translation mechanism available to knowledge brokers to enhance dissemination of 
evidence-based strategies and support adoption and implementation is the “technical 
package” for STLT agency practitioners (Frieden, 2014). This mechanism combines 
evidence translation with capacity building for implementation and evaluation. In this paper, 
we review the use and limitations of systematic reviews for public health action, the concept 
of technical packages as a mechanism for translating systematic review findings into 
actionable recommendations, and provide examples of technical packages in injury and 
violence prevention to illustrate the potential contributions to practice improvement. We also 
provide suggestions for how systematic review methods can be improved to facilitate their 
use, applicability, and integration within technical packages.
The Use and Limitations of Systematic Reviews
A systematic review is “a scientific investigation that focuses on a specific question and that 
uses explicit, planned scientific methods to identify, select, assess, and summarize the 
findings of similar but separate studies. It may or may not include a quantitative synthesis of 
the results from separate studies (meta-analysis)” (IOM, 2011, p241). Well-conducted 
systematic reviews summarize a body of research evidence, identify the research questions, 
explain how the strategies investigated link to the outcomes, and critically appraise study 
quality using a rigorous method. Organizations dedicated to improving evidence-based 
decisions, such as the Cochrane Collaboration, have outlined fundamental criteria for high 
quality systematic reviews that attend to processes such as defining review questions, 
developing criteria for including studies, searching for studies, collecting studies and data, 
assessing risk of bias, analyzing data and undertaking meta-analyses, addressing reporting 
bias, presenting results, interpreting results, and drawing conclusions (see Higgins & Green, 
2008 for more details). Reviews can provide epidemiologic information about factors that 
place individuals and communities at risk for a given health burden, as well as evaluative 
information about prevention strategy effectiveness.
Although systematic reviews can help practitioners identify “best bets” for public health 
impact, they have limitations. Investigators often employ strict criteria for study inclusion in 
reviews, summarize evidence for strategies without prioritizing for specific populations or 
contexts, and do not typically address implementation or fit. These limitations result in 
consideration of only a portion of information that is needed to inform public health action.
Limited scope and criteria
Investigators usually employ strict inclusion criteria (e.g., randomized trials or high quality 
quasi-experimental studies) or limit the review to narrowly defined programs when 
conducting systematic reviews (Valentine, Wilson, Rindskopf et al., 2016). Hence, the 
studies included are often limited in number, conducted in tightly constrained environments, 
within specific local contexts, and with limited time for follow-up to detect sustained health 
impact. Some public health topics, such as prescription drug overdose, are emerging 
research areas where few strategies are known to be effective (Haegerich, Paulozzi, Manns, 
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& Jones, 2014). Further, evidence for community-level or policy strategies is often less 
plentiful than evidence for strategies that modify individual (e.g., problem-solving) and 
relationship (e.g., communication) factors (David-Ferdon & Simon, 2014; US Department of 
Health and Human Services, 2001). When there are few high quality studies available for 
review, the evidence that is synthesized can become truncated, identifying few promising or 
effective strategies for consideration by STLT agencies.
As a general principle, strategies should be implemented at a large scale when there is strong 
evidence of effectiveness behind them. There is risk associated with implementing strategies 
in a widespread manner that have not yet been subjected to rigorous evaluation – risk for 
inefficient use of resources and iatrogenic effects. Tension arises when a health problem is at 
epidemic status (e.g., prescription drug overdose), the number of identified effective 
strategies is low, and STLT agencies require guidance given consequences of inaction (e.g., 
declining health of a population); yet, history suggests that null results are often found when 
strategies are rigorously evaluated or evaluated at scale (Epstein & Klerman, 2012). When 
systematic reviews can only point to a small number of strategies, but the public health 
burden is high, it is necessary to prioritize the strategies with the most rigorous data 
supporting them, but also offer supplemental guidance to address the problem. A mechanism 
is needed to review additional research evidence; assess population characteristics, needs, 
values, and preferences; and leverage resources including practitioner expertise to make 
evidence-based public health decisions (Brownson et al., 2009). A mechanism is also needed 
to provide guidance on implementation and evaluation metrics so that strategies with limited 
evidence are selected for pilot implementation only in a defined area, and practitioners are 
provided guidance on collecting data on intended outcomes; this approach can help identify 
which strategies should be prioritized for more rigorous evaluation to build the evidence 
base before large-scale rollout (Epstein & Klerman, 2012).
Lack of prioritization
In some areas, such as youth violence and motor vehicle injury, there is an extensive 
research history with systematic reviews of numerous prevention strategies. STLT agency 
practitioners need guidance to appropriately select strategies. Too large a number of 
strategies selected for implementation could result in more costly and unwieldy programs 
with a lower likelihood of success (Frieden, 2010). To adequately prioritize interventions 
and choose those that are most likely to have success in a specific context, practitioners need 
information on variables such as quality of materials, flexibility, time requirements, 
complexity, and cost that have been found to predict adherence, core component 
implementation, dosage, and sustainability (Mihalic & Irwin, 2003). Yet, this information is 
commonly not presented within systematic reviews. For example, intervention cost and 
return on investment are important issues for practitioners and often a deciding factor for 
implementation (Raghavan, 2012). Acting on misguided, costly recommendations could 
waste scarce resources, and result in unintended consequences, such as exacerbating the 
outcomes interventions intend to prevent (Braveman, 2007). If economic information was 
more readily shared with evidence of intervention effectiveness from systematic reviews, 
STLT agency practitioners could use this information to make informed decisions about 
whether or not to pursue a specific strategy.
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Absence of information about implementation and fit
Systematic reviews often provide minimal or uneven information that can be used to address 
implementation and variation in fit across environments (Roen et al., 2006; Paulsell, 
Thomas, Monahan, & Seftor, 2016). Only recently have there been innovations in systematic 
review methods to allow for incorporation of qualitative research, such as program 
implementation data (Higgins & Green, 2008). STLT agencies vary in populations served, 
risk and protective factors experienced, and community capacity and infrastructure, making 
it difficult to generalize findings and identify the best interventions to be implemented. For 
example, systematic reviews indicate that publicized sobriety checkpoint programs can 
significantly reduce alcohol-impaired driving and associated fatalities (Bergen et al., 2014). 
When communities implement these programs, the local environment varies (e.g., legal 
restrictions, law enforcement capacity). Although broad implementation of sobriety 
checkpoints could be beneficial, experience shows it is challenging to do because of 
variation in state laws that authorize checkpoint use and variation in enforcement. Guidance 
needs to be provided beyond what is typically included in systematic reviews so that 
implementers can anticipate and plan for legislative barriers (Lavis et al., 2005) and the local 
enforcement environment. A translation mechanism that goes beyond systematic review 
findings and discusses challenges and how strategies can be implemented in different ways 
may better equip STLTs to consider and address their unique community assets and 
challenges and increase their use of evidence-based strategies. Thus, systematic reviews 
include necessary, but not sufficient, guidance for STLT agencies.
The Technical Package Concept
What are technical packages?
As described by Frieden (2014), technical packages outline a narrow range of evidence-
based strategies to address a specific public health problem, along with the estimated costs 
and impacts. The purpose is to provide concrete evidence-based guidance to STLT agencies 
to help them select, implement, and evaluate prevention strategies to improve health and 
social outcomes. The audience includes STLT public health practitioners. Scientists and 
program administrators within the federal government, nonprofit agencies, and academic 
institutions, serving in the role of knowledge brokers (Meyer, 2010; Ward, House, & Hamer, 
2009), develop technical packages. STLT public health practitioners can use technical 
packages when planning programmatic efforts (e.g., in response to funding opportunity 
announcements). A narrow range of evidence-based strategies is desired so that STLT 
practitioners are guided to implement the most effective, feasible, scalable, and sustainable 
interventions identified through rigorous evaluation. Yet, a number of options are desired so 
that STLT practitioners can select the strategies that address the key risk and protective 
factors that are apparent in their own community. Within the package, users can find a suite 
of interventions that when implemented create synergy and enhance public health impact 
(Frieden, 2014). Interventions are typically selected for the package based on feasibility of 
implementation and evidence from systematic reviews or rigorous evaluation studies (e.g., 
randomized controlled trials or quasi-experimental evaluations) showing impact on the 
health outcome or the risk and protective factors associated with the outcome; interventions 
with emerging evidence that address high burden issues and known risk factors might also 
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be selected, with refinements made when results of rigorous evaluation become available. 
Technical packages can further evidence-based public health action by placing research 
evidence within the context of population and community needs, capacities, resources, and 
environment/organizational contexts (Brownson et al, 2009). They may also facilitate 
translation when implementation and evaluation guidance are included. In injury and 
violence prevention, technical packages are a new method for translating scientific 
information. Knowledge brokers within the public health field are starting to conceptualize 
the components and how they could be structured.
How are systematic reviews used in technical packages?
Systematic reviews are valuable tools for the development of technical packages as they 
assist in identifying at-risk populations and promising or effective strategies based on 
research. For example, epidemiologic systematic reviews on risk and protective factors that 
contribute to injury burden, such as individual (e.g., socio-demographics), relationship (e.g., 
supervision), community (e.g., social capital), and societal (e.g., existing policies and 
systems) factors can identify which populations have the greatest injury burden, the factors 
that increase their risk, and the contexts that need to be modified to mitigate harm. 
Evaluation systematic reviews on policy, program, and practice effectiveness can assist in 
identifying which types of strategies have impacts on knowledge, attitudes, behaviors, 
health, and other violence/injury outcomes over multiple trials, contexts, and samples. They 
can signal which strategies might be promising when there is a limited evidence base, and 
indicate which strategies might be most effective when rigorous studies are plentiful.
How do technical packages extend traditional evidence synthesis?
Technical packages go beyond communicating to STLT agency practitioners which 
strategies are most promising or effective based on the scientific evidence. Other 
mechanisms serve this limited purpose. For example, evidence-based program registries 
typically provide a compilation of programs that are intended to prevent specific health 
outcomes. Blueprints for Healthy Youth Development is one such registry that provides 
information about evidence-based programs which impact problem behavior, such as youth 
violence, education, emotional well-being, physical health, and positive relationships (http://
www.blueprintsprograms.com/). While ratings are provided for programs so that users can 
judge the level of evidence of effectiveness (e.g., model, promising) with benefits and costs, 
guidance is not provided on how to select a particular program or set of programs from the 
list or about which are most feasible, scalable, sustainable, or work in a synergistic fashion. 
Registries are typically limited to programs, and are not broadly inclusive of system changes 
or policies – that is, registries tend to focus on interventions that have specific structured 
implementation at individual, family, or community levels. In the rare instances where 
systems changes or policies are included, they are usually specific to an organization 
implementing the intervention (e.g., school policy/systems change implementation to 
improve the behavioral environment, such as in Positive Behavioral Interventions and 
Supports; archived in the Substance Abuse and Mental Health Services Administration’s 
(SAMHSA) National Registry of Evidence-Based Programs and Practices), and do not 
represent broader legislation or regulation, for example at the state level. Technical packages 
extend traditional evidence synthesis and registries by highlighting strategies that target 
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constellations of risk and protective factors at multiple levels of the social ecology; thus, 
when implemented in combination with one another, strategies might have synergistic 
impact. Other mechanisms like planning systems assist communities in planning, 
implementing, and evaluating the impact of programs. Getting to Outcomes (Wandersman, 
Imm, Chinman, & Kaftarian, 2000), for example, leads practitioners through a 10-step 
process of identifying underlying needs and conditions, goals and objectives, best practices, 
fit to community context, resources needed, program plans, process evaluation, outcome 
evaluation, improvement plans, and sustainability. Planning systems typically do not specify 
the prevention strategies that are preferable for selection or are likely to have the greatest 
impact in a given context.
What are the key components of technical packages?
Technical packages triage and prioritize the list of available strategies for STLT agency 
practitioners, focusing on those strategies that are likely to have the greatest synergistic 
impact (that is, provide an effect on outcomes that is greater than the effect that would be 
seen by a series of interventions implemented separately) (see Figure 1 for a summary of 
key components of technical packages). Technical packages can highlight new and 
innovative strategies that show promise but require further evaluation, as well as well-
established strategies where the evidence is strong. Strategies can be prioritized by 
examining the effect estimates across studies, selecting interventions with specific 
components to allow for coverage across outcomes and mechanisms of action, identifying 
the potential harms of specific interventions, assessing applicability of interventions to 
specific settings, or gathering information on acceptability or cost constraints (e.g., see 
Glasziou et al., 2014). Importantly, technical packages can provide guidance on 
implementation and evaluation. The mere discovery of prevention strategies that work does 
not ensure their use. Even after identifying “what works” and packaging materials for 
widespread use, most evidence-based strategies are not adopted and implemented in practice 
settings, and when adopted are often implemented ineffectively (Fixsen, Naoom, Blasé, 
Friedman, & Wallace, 2005; Sloboda, Dusenbury, & Petras, 2014). Translation (sometimes 
termed “dissemination” or “implementation”) research has illuminated factors that impede 
or promote the adoption and use of evidence-based strategies (Fixsen et al., 2005; 
Wandersman, Duffy, Flaspohler, Noonan, & Lubell et al., 2008; Glasgow, Lichtenstein, & 
Marcus, 2003). Hence, well-designed technical packages must penetrate the “black box” 
between research and practice, and incorporate the spectrum of activities that run from 
scientific discovery to research synthesis, capacity building, dissemination, adoption and 
implementation (Wandersman et al., 2008; Noonan & Emshoff, 2013).
Consistent with diffusion of innovation principles, technical packages should attend to the 
factors that influence whether STLT practitioners will try something new: That is, technical 
packages should have clearly communicated messages, be easy to use, include evidence-
based strategies that can be implemented on a trial basis, and illustrate how the included 
strategies are better than other policies or practices that have been previously tried (i.e., have 
a relative advantage) and will have observable results (Rogers, 1962). These factors enhance 
efforts to promote evidence-based strategies and stimulate adoption. Further, adoption and 
use are driven by the fit of the strategy with the current needs and preferences of the 
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implementing organization, as well as the climate for implementation – the organizational 
culture, administrative support, training, and other reinforcements for implementing that 
particular strategy (e.g., Klein & Sorra, 1996). And after a new strategy is adopted, the 
quality of the implementation – that is, whether the technical package is used effectively – 
rests on selection of staff, implementer training, and other “core components” that explain 
implementation outcomes (Fixsen, Blase, Naoom, & Wallace, 2009). Therefore, to ensure 
adoption and use, developers of technical packages should understand their intended 
audience’s needs and preferences when developing the content to maximize natural spread 
of the interventions. Because information alone is rarely sufficient to change practice or 
policies, developers are encouraged to scale up the interventions through dissemination and 
marketing of the materials to STLT agency practitioners (and potentially other audiences, 
including elected officials or other key decision makers in states) and training of 
implementers based on the difficulty of the package’s specifications, while emphasizing how 
the package fits their organizational characteristics.
Technical packages begin in the knowledge creation funnel of the Knowledge to Action 
cycle (Straus, Tetro, & Graham, 2009), in which translation is seen as a dynamic and 
complex process. The technical package is a product that is developed by knowledge brokers 
who clearly identify the problem to be addressed, review and select evidence, adapt the 
evidence to likely implementation contexts, assess barriers to evidence use, and select and 
prioritize interventions for implementation. The technical package also serves as a tool that 
guides users on the action cycle, providing instructions on adaptation, monitoring, 
evaluation, and sustainability. The technical package process is a dynamic one; that is, 
packages are updated as programmatic efforts are implemented and evaluation activities 
identify successes and barriers in changing intended outcomes.
What is the evidence that technical packages can improve public health?
Although evaluation is needed to understand the utility and impact of technical packages, 
there is some evidence to suggest that they are a promising translation strategy. For example, 
in the area of tobacco control, use of a global policy technical package consisting of six 
evidence-formed interventions (MPOWER) was associated with a significant decrease in 
smoking across 5 WHO regions in an exploratory analysis, with greater decreases seen in 
countries with higher levels of implementation (Dubray et al., 2014). Further, the 
Communities that Care (CTC) prevention system is consistent with the technical package 
concept, supplemented by intensive implementation and evaluation technical assistance. 
CTC is a data-driven strategic prevention planning model that supports communities in 
assessing local risks and protective factors and connects this information to a suite of 
evidence-based interventions to reduce violence, delinquency, and substance use among 
young people, in addition to guidance on mobilization of community stakeholders to 
collaborate in the selection, installation, and monitoring of the prevention system (Hawkins 
et al., 2012). In a randomized trial of CTC, increases were seen in the use of evidence-based 
programs in intervention communities compared to control communities (Fagan et al., 
2011), and after several years, significant reductions were detected for delinquency, 
violence, and substance use, even after intensive implementation support ended (Hawkins et 
al., 2012). Greater evaluation is needed of the technical package concept to understand if 
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package dissemination can result in successful implementation and health impact, or if 
technical assistance is needed for successful use, and how much. Consistent with principles 
for evaluation of complex interventions (Bamberger, 2012), evaluation strategies might 
include mixed-methods approaches that combine quantitative and qualitative approaches to 
assess intervention adoption and fidelity of implementation, tracking of technical assistance, 
and assessment of key outcomes.
Exemplars in Injury and Violence Prevention
To illustrate the concept of the technical package, show how systematic reviews are an 
important component, and highlight opportunities and challenges in development, we 
provide exemplars in the area of prescription drug overdose, youth violence, and motor 
vehicle injury prevention, three areas of great public health burden (see Table 1). The 
exemplars illustrate initial conceptual frameworks. Packages are in various stages of 
development, and have not yet been fully released or implemented with key audiences; when 
available, these packages can be accessed from the CDC Injury Center website (http://
www.cdc.gov/injury/). We highlight the health burden justifying the injury topics addressed, 
the systematic review foundation for selection of evidence-based strategies, the limitations 
of the evidence base for informing practice, the importance of providing supplemental 
implementation and evaluation guidance, and the challenges faced when developing 
technical packages for population-level impact while attending to adaptation and unique 
community needs. The process for developing these specific technical packages has been 
varied and is ongoing; however, common features of development are summarized in Figure 
1. These packages complement other injury and violence prevention packages recently 
published in the areas of child abuse and neglect and sexual violence prevention, available at 
http://www.cdc.gov/violenceprevention/pub/technical-packages.html (Fortson, Klevens, 
Merrick, Gilbert, & Alexander, 2016; Basile, DeGue, Jones, Freire, Dills, Smith, & 
Rainford, 2016).
Prescription drug overdose prevention
The United States is in the midst of a prescription opioid overdose epidemic. From 1999 to 
2014, over 165,000 Americans have died from an overdose involving prescription opioids. 
Deaths are starting to decline for the first time in 15 years, but still a large number of people 
continue to die from these drugs – over 14,000 in 2014 (CDC, 2016). In parallel with death 
trends, from 1999 to 2008 opioid prescriptions quadrupled (CDC, 2011). Because overdose 
deaths and opioid sales rose together in lockstep, many researchers and organizations have 
focused on inappropriate prescribing – and all the policies and systems that have supported it 
– as a key driver (Dowell, Kunins, & Farley, 2013; Kenan, Mack, & Paulozzi, 2012; 
Kirschner, Ginsburg, & Sulmasy, 2014).
States have implemented interventions to address problematic prescribing and risky patient 
behaviors, but the evidence base is limited. In a systematic review, Haegerich, Paulozzi, 
Manns, and Jones (2014) summarized the evidence for prevention approaches. The 
investigators reviewed multiple strategies within one comprehensive review and analyzed 
effects on provider behavior, patient behavior, and health outcomes. Overall, there were a 
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small number of evaluation studies and study quality was low. There is some promising 
evidence for prescription drug monitoring programs (PDMPs), insurer strategies (e.g., 
patient review and restriction, drug utilization review, prior authorization), pain clinic 
legislation, clinical guidelines, and naloxone distribution programs for improving 
prescribing and patient outcomes (Haegerich et al., 2014). These strategies are considered 
promising because although there were positive outcomes, evaluation studies used designs 
with methodological weaknesses, such as lack of baseline data and comparison groups, 
inadequate statistical testing, small sample sizes, self-reported outcomes, and short-term 
follow-up. The systematic review provides evidence to support an initial prioritization of 
interventions for states and health systems, but lacks detail needed to create a technical 
package. This omission is unfortunate, given the urgency of the problem and frequent state 
demands for technical assistance to address the epidemic.
In response, CDC is funding state health departments through a new $70M program entitled, 
Prescription Drug Overdose Prevention for States. This program is designed to enhance, 
implement, and evaluate state-level interventions that have the potential to address the 
problem: enhancement of PDMPs, implementation of insurer and pharmacy benefit manager 
mechanisms (e.g., prior authorization, drug utilization review), and evaluation of state 
policies, rules, or regulations (e.g., pain clinic regulation, doctor shopping, Good Samaritan 
laws). Because the quality of evidence for these strategies is low, we need to grow the 
evidence base by conducting evaluations of these efforts, with a careful eye toward 
implementation factors that influence both adoption and health outcomes. The funded states 
will engage in both implementation and evaluation efforts, providing an opportunity for 
these states to become laboratories for greater innovation and evaluation of “what works.” In 
essence, systematic review findings are being used to directly inform funding for 
programmatic efforts, as with other recent federal initiatives (e.g., teen pregnancy 
prevention; Goesling, Oberlander, & Trivits, 2016), with evaluation components built in to 
support further development of the evidence base.
To scale up this program, CDC is in the process of drafting a technical package that will 
leverage both the systematic review and what is known about effective knowledge 
translation – responding to the target audience’s expressed needs and preferences; making 
the package easy to use by providing a short prioritized list of options; offering technical 
assistance and training on the suite of interventions in the package to build implementation 
capacity; disseminating materials when audiences are ready to receive them; providing clear 
guidance and training on implementation; and providing evaluation metrics so states can 
monitor their own progress. In the area of PDMPs, for example, effective components likely 
include universal use (all controlled substances are included and all prescribers check it 
before writing a prescription), real-time data, and active management (reports are 
proactively sent to stakeholders to alert them to aberrant prescribing or use). However, each 
state has a different PDMP configuration and set of rules that apply to its use. Table 2 
provides example content to be included in the technical package. While the systematic 
review provides information on the purpose, target population, and rationale for PDMPs 
with key findings about impact, the package provides more information about needed 
resources, implementation activities, opportunities, challenges, key evaluation metrics, 
resources and tools, and example case studies of success in states.
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Youth violence is when young people intentionally use physical force or power to threaten or 
harm others. There are many forms, such as fighting, bullying, threats with weapons, and 
gang-related violence. Youth violence is a significant public health issue with homicide 
being the third leading cause of death among 10–24 years-olds (CDC, 2014). A strong 
research base and several systematic reviews demonstrate that youth violence can be 
prevented (e.g., USDHHS, 2001; Center for the Study and Prevention of Violence, n.d.; 
CDC, n.d.; Office of Justice Programs, n.d.; Substance Abuse Mental Health Services 
Administration, n.d.). Evidence-based approaches include those that build youth’s skills to 
avoid violence as well as parenting and family-focused strategies that provide support and 
teach communication, problem-solving, monitoring, and behavior management skills. 
Systematic reviews have found these strategies are effective in reducing youth violence 
among broad groups of youth and among youth at greatest risk (e.g., chronic offenders, 
youth in families with high levels of conflict). Research is emerging about community- and 
societal-level prevention strategies (Masho, Bishop, Edmonds, & Farrell, 2014; Webster, 
Whitehill, Vernick, & Curriero, 2012; MacDonald, Golinelli, Stokes, & Bluthenthal, 2010), 
but this area is not developed enough yet to have associated systematic reviews. Growing 
benefit-cost information shows that the financial savings of evidence-based programs can far 
outweigh costs (Washington State Institute for Social Policy, n.d.; Center for the Study and 
Prevention of Violence, n.d.).
The accessibility of information about evidence-based approaches has improved with free, 
online systematic reviews (e.g., Community Guide, Blueprints for Healthy Youth 
Development). Although useful, these resources include information about strategies for a 
wide-range of health topics (i.e., not just youth violence), information is sometimes out of 
date, and communities still need to sift through technical information across multiple 
resources and publications to determine which intervention should be prioritized based on 
evidence and needs (Mihalic & Elliott, 2015). These systematic reviews also typically lack 
information about the community capacity and infrastructure requirements, which is 
necessary to successfully implement evidence-based approaches (Puddy & Wilkins, 2011).
CDC provides technical assistance and develops tools to increase the capacity of STLT 
agencies to use evidence-based approaches to prevent youth violence. For instance, CDC’s 
Preventing Youth Violence: Opportunities for Action and its companion guide (David-
Ferdon & Simon, 2014) has components consistent with a technical package. The guide 
presents the trends, disparities, and causes of youth violence that need to be considered with 
designing a strategic prevention approach. The resource presents a range of evidence-based 
prevention strategies and cost estimates informed by systematic reviews. Online systematic 
reviews (e.g., Blueprints for Healthy Youth Development, Community Guide), capacity to 
implement and sustain prevention strategies, and evidence-based action steps for multiple 
groups (e.g., public health, community leaders and members, parents and other caregivers, 
and youth) are discussed.
CDC’s Preventing Youth Violence: Opportunities for Action and its companion guide are 
providing a foundation for a technical package that is currently in development at the CDC. 
This technical package will address the limitations of the existing guides as they do not have 
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a narrowed focus on the most effective, feasible, scalable or sustainable strategies; rather, 
what is broadly known about prevention strategies is presented. Although some examples of 
cost effectiveness data are presented, estimates are not provided about every prevention 
strategy as these data are emerging. Nonetheless, these resources bridge the gap between 
science and practice and make what is known about preventing youth violence accessible.
Developers of the youth violence technical package are wrestling with the fact that the 
causes and appropriate prevention strategies can vary significantly across communities. 
Although an ideal technical package might have a focused list of specific prevention 
strategies, this approach for youth violence could result in too small a range of programs. 
Research comparing the relative effectiveness of evidence-based programs is limited, which 
creates challenges to prioritizing programs. The technical package currently in development 
is envisioned to provide a menu of evidence-based prevention strategies (e.g., strengthen 
youth’s skills) that is complemented by approaches (e.g., universal school-based programs) 
to advance the strategy and examples of specific programs (e.g., Good Behavior Game, Life 
Skills Training). Implementation guidance for the technical package will also be developed 
that may include case studies to illustrate how communities could begin with the general 
menu of strategies and ultimately select approaches and programs that are the most feasible, 
scalable, and sustainable based on their risk factor/asset profile as well as more information 
about program costs and delivery considerations. The usefulness of this technical package 
could be supplemented by technical assistance and tools, such as CDC’s STRYVE Strategies 
Selector Tool (http://vetoviolence.cdc.gov/stryve/strategy_pdf.html), that helps communities 
build capacity to select approaches that match local needs, implement them effectively, and 
evaluate their effects.
Motor Vehicle Injury Prevention
American Indians and Alaska Natives (AI/AN) are at increased risk for motor-vehicle crash 
(MVC)-related injury and death with rates 1.5 to 3 times higher than rates of other 
Americans. Several factors place AI/AN at increased risk including low rates of seat belt and 
child safety seat use and a high prevalence of alcohol-impaired driving (NHTSA, 2014). To 
address this disparity, tribal motor vehicle safety programs have been funded by the CDC 
and the Indian Health Service (IHS). CDC funded 12 Tribal Motor Vehicle Injury Prevention 
Programs (TMVIPP) and the IHS Tribal Injury Prevention Cooperative Agreement Program 
(TIPCAP) funded 35 tribes to tailor effective motor vehicle injury prevention interventions 
in tribal communities. Both programs required implementation of motor vehicle safety 
evidence-based strategies systematically reviewed by the Community Guide and 
recommended by the Community Preventive Services Task Force, including increasing child 
safety seat use, increasing seat belt use, and decreasing impaired driving (Dinh-Zarr et al., 
2001; Shults et al., 2001: Zaza et al., 2001). Tribes selected strategies for implementation 
and then prioritized available interventions for each strategy.
For agency and tribal perspectives, CDC convened six tribes and the four federal agencies 
funding them (CDC, IHS, Bureau of Indian Affairs, and National Highway Traffic Safety 
Administration) to identify essential components of tribal traffic safety programs. A list of 
essential components was developed based on tribal and agency experiences and evaluation 
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in the areas of 1) program requirements and administration, 2) partnership and collaboration, 
3) data collection and program evaluation, and 4) tailoring effective strategies. The list of 
components served as a resource for federal agencies to inform future AI/AN programs.
A technical package is currently in development for tribes based on the lessons learned from 
the CDC and IHS programs, essential components of tribal traffic safety programs, and on 
the Community Preventive Services Task Force recommendations. The technical package, 
Tribal Motor Vehicle Injury Prevention Best Practices Guide, includes a description of the 
evidence-based policies and programs, along with guidance on adaptation for tribal 
populations and implementation strategies. Effective policies and programs identified based 
on systematic review include child safety seat laws, community-wide information and 
enhanced enforcement campaigns, safety seat distribution and education programs; primary 
seatbelt enforcement laws and enhanced enforcement programs; and for alcohol-impaired 
driving prevention .08% Blood Alcohol Concentration (BAC) laws publicized sobriety 
checkpoints, and multicomponent programs (Bergen et al., 2014; Dinh-Zarr et al., 2001; 
Elder et al., 2004; Elder et al., 2005; Shults et al., 2001; Shults et al., 2009; Zaza et al., 
2001). Case examples are being included in the technical package to summarize tribal 
experience in implementing the selected strategies, garnering support, and identifying 
resources and tools available for evidence-based strategies. The technical package is 
accompanied by the Roadway to Safer Tribal Communities Toolkit comprised of fact sheets, 
brochures, posters, a short video, and a tutorial in CDC’s Web-based Injury Statistics Query 
and Reporting System (WISQARS) featuring AI/AN examples (http://www.cdc.gov/
motorvehiclesafety/native/toolkit.html).
Presently, there are 547 federally-recognized tribes in the US, all with varying cultures, 
governments, laws, infrastructure, and capacity. The Community Guide recommendations 
are based on research in non-tribal communities and pose challenges related to applicability 
in tribal populations with different infrastructure and policy options. For example, strongly 
recommended enhanced enforcement is not an option for tribes without police departments 
or detention facilities. Supplemental information and guidance is needed to complement 
systematic reviews of strategies, even when the strategies are broadly recognized as 
effective. In the case of tribes, a technical package that provides successful tailored tribal 
case examples can ease the skepticism that often accompanies efforts to implement model 
programs in a dissimilar setting.
To stimulate adoption of best practices within tribal communities using the technical 
package, CDC is collaborating with the Federal Highway Administration to provide 
technical assistance to tribes within the 3 regional Tribal Technical Assistance Program 
(TTAP) centers in the western US. This pilot program has the potential to reach 207 tribes in 
10 states.
Improving Systematic Reviews to Facilitate Their Use
While systematic reviews contribute to technical package development as highlighted in the 
exemplars, review methods could be enhanced to facilitate use. For example, systematic 
reviews could better incorporate logic models that illustrate components of the policy or 
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practice (e.g., duration, administration), the characteristics of target population, the settings 
for implementation, and the causal pathways that influence health outcomes (Anderson et 
al., 2011). Including more contextual information within systematic reviews can reduce 
barriers to dissemination by explicating common factors that can inhibit adoption, such as 
requirements for implementation strategies, scale-up, cost/resources, setting characteristics, 
incentives or regulations, reach, and sustainability. Such data might come from qualitative 
components of original quantitative research studies, related quality improvement efforts in 
the field, and marketing/opinion polling of the target population (Glasgow & Emmons, 
2007) and could be highlighted within systematic review translation websites (Paulsell et al., 
2016). Conducting systematic reviews in a staged approach, such as by developing an 
overview of reviews or gap maps (Da Silva, Zaranyika, Langer et al., 2016), can help 
identify where evidence is strong and where it is missing, and better inform which 
interventions should be prioritized for implementation and which should be subjected to 
rigorous evaluation if they are selected for implementation. When the number of studies 
available for synthesis are low, Bayesian analysis could be considered to generate estimates 
of intervention effectiveness (Valentine et al., 2016).
Reporting guidelines for systematic reviews could also include criteria that encourage 
authors to specify policy and practice implications of the findings. Decision makers have 
reported that inclusion of summaries with policy recommendations within reviews can 
facilitate the use of evidence (Innvaer, Vist, Trommald, & Oxman, 2002). The PRISMA 
statement (Moher, Liberati, Tetzlaff, & Altman, 2009), a tool that assesses the quality of 
systematic reviews, rates reviews on whether the authors provide a general interpretation of 
the results in the context of other evidence, and implications for future research, as well as a 
description of the relevance of the findings to key groups. However, PRISMA guidance, or 
guidance for other systematic review assessment tools, could be expanded to include explicit 
assessment of the degree to which authors provide contextual information about 
implementation factors, cost considerations, applicability to diverse populations, policy 
considerations, and use for development of practice recommendations.
Conclusion
Systematic reviews are valuable for the construction of technical packages for STLT agency 
practitioners that describe evidence-based strategies, along with the estimated costs and 
impacts. Technical packages are newly developing in injury and violence prevention. As the 
concept evolves in all areas of public health, it will be important to share lessons learned 
across health topics, including how technical packages have influenced strategy adoption 
and implementation, and health impact. Evaluations can test their utility and fill gaps in our 
knowledge about how to disseminate and implement evidence-based strategies (Brownson, 
Dreisinger, Colditz, & Proctor, 2012). As injury and violence prevention technical packages 
are developed and implemented by communities, it is critical to collect data to evaluate local 
use, and determine needs for modification and supplementary technical assistance. As the 
evidence-base grows, a revision loop should be implemented so that technical packages 
continue to provide the most up to date evidence and implementation guidance for 
communities.
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Table 2
Illustration of the Prescription Drug Overdose Prevention Technical Package – Prescription Drug Monitoring 
Program Strategy
Strategy Example Prescription Drug Monitoring Programs
Description • Programs that require state pharmacies to submit all information on prescriptions filled for 
controlled substances electronically to a central office, such as the health department or board 
of pharmacy.
• Information is provided to prescribers about patients using multiple prescribers or pharmacies, 
and in some cases to law enforcement about aberrant prescribing.
Purpose • Improve patient care by helping to identify patients at risk of abuse, addiction and overdose
• Improve prescribing by empowering healthcare providers to make informed prescribing 
decisions (avoid duplicate or overlapping prescriptions; avoid potentially dangerous/fatal 
interactions)
• Increase surveillance capacity at the state level and inform/evaluate prevention strategies
Target Population • Prescribers
• Dispensers
Essential Components • Universal (registration and use)
• Real-time (reporting within 24 hours)
• Actively managed (proactive reporting)
Role of State Health 
Department
• Dependent upon sponsoring entity of PDMP data – state health department as primary 
implementer or partner with PDMP coordinating agency and other stakeholders
Rationale • Increased registration and use of PDMP data has been linked with decreases in prescribing of 
opioids (and controlled substances overall), doctor shopping (multiple provider episodes), and 
opioid overdose
Evidence Level • Promising
Implementation Activities • Encourage use of PDMP data by prescribers and dispensers
• Collaborate with stakeholders to increase consistency, accuracy, completeness and timeliness 
of data
• Issue proactive prescription history alerts regarding patients at risk or inappropriate prescribing
• Integrate PDMP data with electronic health records
• Disseminate findings to increase awareness of public health issue
Resources • May require staffing increases for project management, administrative support and 
programming
• New electronic servers may be needed to handle anticipated increase in system demand
Opportunities • State health departments can work with other agencies (e.g., Medicaid, Medicare) to integrate 
PDMP data in patient care to identify patients at risk and/or in need of changes to treatment 
regimen in order to improve patient care
• Mandates can greatly increase PDMP registration and use by providers
Challenges • Increased financial and staffing resources to make enhancements to operations and 
infrastructure
• Data security and privacy concerns
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Strategy Example Prescription Drug Monitoring Programs
• Legal or regulatory constraints
Key evaluation metrics • % End users partially or completely satisfied with PDMP
• % Prescribers and dispensers registered
• % Prescribers and dispensers accessing data




• Multiple provider episodes
Data sources • Prescribers (physicians, nurses, other clinicians)
• Pharmacies/dispensers
• State prescription drug monitoring program
Case Study • Oklahoma: Describe efforts to enable data capture within 5 minutes of prescriptions being 
dispensed; summarize keys to success (e.g., partnership, advisory committee, procedural 
review, work flow integration); review costs and control measures; summarize results (e.g., 
time lag, PDMP use)
Resources and Tools • Prescription Drug Monitoring Program Training and Technical Assistance Center http://
www.pdmpassist.org/
Evidence Resources • Haegerich TM, Paulozzi LJ, Manns BJ, Jones CM. What we know, and don’t know, about the 
impact of state policy and systems-level interventions on prescription drug overdose. Drug and 
Alcohol Dependence. 2014;145:34–47.
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